Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Stress and aging induce distinct polyQ protein aggregation states.

Moronetti Mazzeo LE, Dersh D, Boccitto M, Kalb RG, Lamitina T.

Proc Natl Acad Sci U S A. 2012 Jun 26;109(26):10587-92. doi: 10.1073/pnas.1108766109. Epub 2012 May 29.

2.

Inhibition of protein misfolding/aggregation using polyglutamine binding peptide QBP1 as a therapy for the polyglutamine diseases.

Popiel HA, Takeuchi T, Burke JR, Strittmatter WJ, Toda T, Wada K, Nagai Y.

Neurotherapeutics. 2013 Jul;10(3):440-6. doi: 10.1007/s13311-013-0184-7. Review.

3.

[Molecular therapy targeting protein misfolding and aggregation for the polyglutamine diseases].

Nagai Y.

Rinsho Shinkeigaku. 2009 Nov;49(11):913-6. Review. Japanese.

PMID:
20030247
4.

Oxidative stress and protein aggregation during biological aging.

Squier TC.

Exp Gerontol. 2001 Sep;36(9):1539-50. Review.

PMID:
11525876
5.

Multi-domain misfolding: understanding the aggregation pathway of polyglutamine proteins.

Saunders HM, Bottomley SP.

Protein Eng Des Sel. 2009 Aug;22(8):447-51. doi: 10.1093/protein/gzp033. Epub 2009 Jul 9. Review.

PMID:
19589877
6.

Towards the treatment of polyglutamine diseases: the modulatory role of protein context.

Robertson AL, Bottomley SP.

Curr Med Chem. 2010;17(27):3058-68. Review.

PMID:
20629626
7.

Molecular chaperones as modulators of polyglutamine protein aggregation and toxicity.

Sakahira H, Breuer P, Hayer-Hartl MK, Hartl FU.

Proc Natl Acad Sci U S A. 2002 Dec 10;99 Suppl 4:16412-8. Epub 2002 Aug 20. Review.

8.

Induction of molecular chaperones as a therapeutic strategy for the polyglutamine diseases.

Nagai Y, Fujikake N, Popiel HA, Wada K.

Curr Pharm Biotechnol. 2010 Feb;11(2):188-97. Review.

PMID:
20166962
9.

Conformational diseases: structural studies of aggregation of polyglutamine proteins.

Papaleo E, Invernizzi G.

Curr Comput Aided Drug Des. 2011 Mar;7(1):23-43. Review.

PMID:
20807186
11.

Analyzing the aggregation of polyglutamine-expansion proteins and its modulation by molecular chaperones.

Kubota H, Kitamura A, Nagata K.

Methods. 2011 Mar;53(3):267-74. doi: 10.1016/j.ymeth.2010.12.035. Epub 2010 Dec 30. Review.

PMID:
21195182
12.

Huntingtin aggregation and toxicity in Huntington's disease.

Bates G.

Lancet. 2003 May 10;361(9369):1642-4. Review.

PMID:
12747895
13.

Neuronal responses to stress and injury in C. elegans.

Kim KW, Jin Y.

FEBS Lett. 2015 Jun 22;589(14):1644-52. doi: 10.1016/j.febslet.2015.05.005. Epub 2015 May 13. Review.

Supplemental Content

Support Center